Precigen (PGEN) Intangibles (2012 - 2026)
Precigen (PGEN) posted quarterly Intangibles of $2.9 million for Q1 2026, down 30.75% year-over-year from $4.1 million in Q1 2025, and down 9.99% quarter-over-quarter from $3.2 million in Q4 2025.
Precigen (PGEN) Intangibles (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Intangibles for 15 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles fell 30.75% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 30.75% YoY), while the FY2025 annual figure was $3.2 million, down 28.57% from the prior year.
- Intangibles slipped to $2.9 million in Q1 2026 per PGEN's latest filing, from $3.2 million in the prior quarter.
- Across five years, Intangibles topped out at $51.4 million in Q1 2022 and bottomed at $2.9 million in Q1 2026.
- Historically, Intangibles has averaged $24.8 million across 5 years, with a median of $38.7 million in 2024.
- Annual changes were most pronounced in 2023 — Intangibles dropped 4.69% — and 2025, when it tumbled 89.32%.
- Precigen's Intangibles stood at $44.5 million in 2022, then declined by 8.44% to $40.7 million in 2023, then sank by 89.05% to $4.5 million in 2024, then fell by 28.57% to $3.2 million in 2025, then slipped by 9.99% to $2.9 million in 2026.
- Business Quant data shows PGEN's Intangibles at $2.9 million in Q1 2026, $3.2 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.55 Mn |
| Mar 31, 2026 | 2.86 Mn |
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Dec 31, 2024 | 4.46 Mn |
| Sep 30, 2024 | 4.77 Mn |
| Jun 30, 2024 | 5.09 Mn |
| Mar 31, 2024 | 38.72 Mn |
| Dec 31, 2023 | 40.70 Mn |
| Sep 30, 2023 | 40.43 Mn |
| Jun 30, 2023 | 42.66 Mn |
| Mar 31, 2023 | 43.85 Mn |
| Dec 31, 2022 | 44.46 Mn |
| Sep 30, 2022 | 42.42 Mn |
| Jun 30, 2022 | 45.93 Mn |
| Mar 31, 2022 | 51.43 Mn |
| Dec 31, 2021 | 52.29 Mn |
| Sep 30, 2021 | 56.91 Mn |